Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-06-24 Sale | 2022-06-28 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner | 341,971 | $21.31 | $7,287,402 | 415,142 (Indirect) | View |
2022-04-06 Sale | 2022-04-08 6:06 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner | 878,200 | $20.68 | $18,163,608 | 451,086 (Indirect) | View |
2022-03-29 Sale | 2022-03-31 5:30 pm | PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC 10% Owner | 474,500 | $21.63 | $10,264,415 | 6,589,330 (Indirect) | View |
2022-02-11 Purchase | 2022-02-15 9:42 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director | 195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) | View |
2021-09-03 Sale | 2021-09-08 6:18 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 8,084 | $33.99 | $274,794 | 96,190 (Indirect) | View |
2021-08-31 Sale | 2021-09-02 8:27 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) | View |
2021-08-26 Sale | 2021-08-30 6:37 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 18,073 | $34.07 | $615,748 | 97,542 (Indirect) | View |
2021-08-23 Sale | 2021-08-25 8:43 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 18,215 | $34.17 | $622,426 | 98,074 (Indirect) | View |
2021-08-17 Sale | 2021-08-19 8:55 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 20,328 | $34.1 | $693,210 | 98,610 (Indirect) | View |
2021-07-16 Purchase | 2021-07-16 4:27 pm | IMARA Inc. | IMRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,666,666 | $6 | $9,999,996 | 4,199,068 (Indirect) | View |
2021-02-17 Purchase | 2021-02-19 7:09 pm | Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,666,666 | $18 | $29,999,988 | 883,418 (Indirect) | View |
2020-12-08 Purchase | 2020-12-08 8:41 pm | Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,190,477 | $21 | $25,000,017 | 1,221,700 (Indirect) | View |
2020-12-02 Purchase | 2020-12-04 6:11 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner | 750,000 | $20 | $15,000,000 | 450,000 (Indirect) | View |
2020-10-02 Purchase | 2020-10-06 5:27 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 496,000 | $25 | $12,400,000 | 902,286 (Indirect) | View |
2020-09-25 Purchase | 2020-09-29 8:10 pm | Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,236,800 | $19 | $23,499,200 | 14,805,377 (Indirect) | View |
2020-09-25 Purchase | 2020-09-29 4:39 pm | PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 950,000 | $18 | $17,100,000 | 475,000 (Indirect) | View |
2020-06-30 Purchase | 2020-07-02 4:02 pm | Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 898,000 | $17 | $15,266,000 | 192,100 (Indirect) | View |
2020-06-23 Purchase | 2020-06-25 5:53 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 774,200 | $20 | $15,484,000 | 99,200 (Indirect) | View |
2020-03-02 Sale | 2020-03-04 4:17 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 1,874,203 | $26 | $48,729,278 | 0 (Indirect) | View |
2020-02-03 Purchase | 2020-02-04 5:30 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 558,888 | $17 | $9,501,096 | 606,286 (Indirect) | View |
2020-01-09 Sale | 2020-01-13 4:48 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 379,997 | $19.5 | $7,409,942 | 38,808 (Indirect) | View |
2019-12-20 Sale | 2019-12-26 4:54 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 519,385 | $19.66 | $10,209,721 | 40,200 (Indirect) | View |
2019-12-17 Sale | 2019-12-19 4:33 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 954,100 | $18.52 | $17,669,932 | 97,700 (Indirect) | View |
2019-08-07 Sale | 2019-08-09 6:41 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC 10% Owner | 650,000 | $17.9 | $11,635,000 | 3,171,804 (Indirect) | View |
2019-02-11 Purchase | 2019-02-11 7:11 pm | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC Director 10% Owner | 411,700 | $19 | $7,822,300 | 203,200 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-07-01 Disposition | 2022-07-01 4:50 pm | N/A N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner | 1,738,066 | $55 | 0 (Indirect) | View |
2022-07-01 Disposition | 2022-07-01 4:50 pm | 2019-11-13 2024-11-13 | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner | 1,477,124 | $0 | 0 (Indirect) | View |
2022-01-26 Exercise | 2022-01-28 9:22 pm | 2020-01-22 N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner | 487,450 | $0 | 226,704 (Indirect) | View |
2022-01-26 Exercise | 2022-01-28 9:22 pm | N/A N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner | 431,206 | $13.2 | 226,704 (Indirect) | View |
2021-02-17 Conversion | 2021-02-19 7:09 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 20,654,719 | $0 | 883,418 (Indirect) | View |
2021-02-11 Ownership | 2021-02-11 9:20 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC 10% Owner | 0 | $0 | 3,278,526 (Indirect) | View |
2020-12-07 Conversion | 2020-12-09 4:24 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 3,240,882 | $0 | 534,599 (Indirect) | View |
2020-12-08 Conversion | 2020-12-08 8:41 pm | N/A N/A | Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner | 33,046,445 | $0 | 1,221,700 (Indirect) | View |
2020-09-25 Conversion | 2020-09-29 8:10 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner | 27,775,930 | $0 | 14,805,377 (Indirect) | View |
2020-09-25 Conversion | 2020-09-29 4:39 pm | N/A N/A | PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 6,114,330 | $0 | 475,000 (Indirect) | View |
2020-06-30 Conversion | 2020-07-02 4:02 pm | N/A N/A | Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 14,102,821 | $0 | 192,100 (Indirect) | View |
2020-06-23 Conversion | 2020-06-25 5:53 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 2,601,325 | $0 | 99,200 (Indirect) | View |
2020-02-03 Conversion | 2020-02-04 5:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 4,114,962 | $0 | 606,286 (Indirect) | View |
2020-01-29 Conversion | 2020-01-31 4:55 pm | N/A N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Global Healthcare GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,496,820 | $0 | 1,477,320 (Indirect) | View |
2020-01-30 Ownership | 2020-01-30 7:52 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner | 0 | $0 | 4,114,962 (Indirect) | View |
2019-11-22 Ownership | 2019-11-26 6:41 pm | N/A N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Global Healthcare GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 0 | $0 | 137,668,050 (Indirect) | View |
2019-02-11 Conversion | 2019-02-11 7:11 pm | N/A N/A | Alector Inc. | ALEC | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ORBIMED CAPITAL LLC Director 10% Owner | 12,682,329 | $0 | 203,200 (Indirect) | View |